ArticleCell research2024

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer.

Li-Ping Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.